Aim: To clinically, biochemically, and microbiologically evaluate the influence of crown margins position on one-stage laser-microgrooved implants.
| INTRODUCTION
In addition to the functional outcome, the esthetic outcome is an equally important key of success of the modern dental implant therapy. From the esthetic point of view, the success is not only bound to the long-term peri-implant soft tissue stability, involving the presence of papilla, and the alignment of the gingival margin in harmony with the implants crown, but, especially in frontal areas, implant-supported restorations should not even be distinguished from the natural dentition. 1 One of current clinical recommendations for esthetic implantsupported crown restorations indicates that the one-stage implant shoulder should be positioned 1-2 mm more apically to the labial cement-enamel junction of the adjacent teeth. 2, 3 This allows to hide the abutment-crown interface, achieve more natural emergence profile, and accommodate possible peri-implant tissue recession with time. However, as the implant shoulder does not match the scalloped cement-enamel junction design of adjacent teeth, the interproximal crown margins are often located several millimeters submucosally, and are thus difficult to reach during the patient's routine oral hygiene efforts. 4 There is general agreement that, around natural teeth, the maintenance of a healthy periodontium is related to the position of restorative margins' position. 5 Several studies have shown that restorative margins placed subgingivally risk invading the attachment apparatus. [5] [6] [7] [8] [9] [10] [11] [12] Moreover, subgingival crown margins were found to be associated with more spirochetes, fusiforms, rods, and filamentous bacteria, and with an increased plaque and gingival index scores, and probing depths. 13 Despite the mentioned risks, some factors including esthetic needs, increased retention form, refinement of preexisting margins, root caries, cervical abrasion, and root sensitivity, may direct the clinician to place the restoration subgingivally. However, if none of these factors is present, it is more prudent to place the restorative margins supragingivally. 5 A combination of clinical and radiographic parameters are commonly used for the diagnostic assessment of peri-implant tissue health.
They are indicative of a well-established peri-implant tissue inflammatory response but do not provide sufficient information to locate the inflammation progression site. 14 Likewise, the gingival crevicular fluid (GCF), the peri-implant sulcus fluid (PISF) is an osmotically mediated transudate/exudate, which tends to increase during the inflammatory process. 15 Several reports suggested that the volume of PISF and levels biomarkers such as, the interleukin-1beta (IL-1β), the interleukin-6 (IL-6), and the tumor necrosis factor (TNF)-α, could be relevant for the early diagnosis of peri-implant tissue inflammation. 16, 17 The specific plaque hypothesis suggests that certain oral bacteria play critical roles in the initiation and progression of both periodontal, 18 and peri-implant inflammation. 19 Despite the fact that recent studies indicated that peri-implant and periodontal microbiomes represent microbiologically distinct ecosystems, [20] [21] [22] and that the host response plays a crucial role in initiation/progression of the inflammation process, 23 the assessment of the levels of periodontitis-associated bacteria may, however, determine whether the deeper location of restoration margins is a predisposing condition of colonization by such bacteria, and therefore, in the susceptible host, is a condition of higher risk to develop a peri-implant inflammation.
To the authors' knowledge, only few data have been published about the influence of restorative crown margins location on the maintenance of peri-implant health conditions. [23] [24] [25] Therefore, the present study was designed to evaluate the influence of the crown margins position on the peri-implant tissue health status around onestage implants supporting screw retained single restorations. For this purpose, in addition to clinical and radiographic parameters, the following biochemical and microbiological parameters were used: volume of PISF, PISF levels of IL-1β, IL-6, and TNF-α, and concentration in PISF of A. actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, and Tannerella forsythensis. All implants were inserted with the rough/microgrooved border placed flush to the bone crest, and the 2 mm of laser-microgrooved surface over the bone crest.
| MATERIALS AND METHODS

| Patients
| Implants
| Clinical examination
The clinical evaluation was performed by one clinician (R.G.) and included measurement of probing pocket depth (PPD) and assessments of the modified plaque index (mPl), 26 of the gingival index (GI), 27 
| PISF SAMPLING AND BIOCHEMICAL ANALYSIS
The PISF was collected with standardized paper strips (Periopaper, Proflow, Amityville, New York) at the 3-year examination. Following the isolation of the sampling area with sterile cotton gauzes, accurate suction was performed and experimental sites were gently air dried to reduce any possible contamination with saliva. Supragingival plaque was removed with teflon or plastic curettes for implant maintenance.
Extreme care was taken to minimize mechanical irritation during PISF sampling because this is known to affect the actual fluid volume. Two paper strips were placed at each sampling site at the same time (mesially and distally), and were left in situ for 30 s. Paper strips contaminated by blood were excluded. To eliminate the risk of evaporation, paper strips with PISF were immediately transported to previously calibrated, switched on and allowed to warm up. Periotron 8000 (Ora Flow, Inc, Plainview, New York) was used for volume quantification.
Before volume measurement, a blank paper strip was placed in the device and the reading dial was set to zero. To increase reliability, the calibration of the device was checked periodically by triplicate readings. The PISF was measured electronically in Periotron units, which were converted to microliters (μL) by MCCONVRT software (Ora Flow).
For the biochemical analysis, the paper strips were placed in a sin- The biomarkers levels were assessed by a micro-ELISA reader (Ultramark, Bio-Rad, California) at 450 nm and normalized to the abundance of standard solution. All biochemical analyses were performed by a blinded researcher.
| Microbiological analysis
The microbiological analysis was performed at the 3-year follow-up examination, by means of real-time polymerized chain reaction (RT-PCR) technique using Carpegen Perio Diagnostics Test (Carpegen GmbH, Münster, Germany) according to the instructions of the manufacturer. Sampling areas were treated as described for PISF sampling and biochemical analysis. Paper points were inserted in four different sites for each implant included in the study (buccal, mesio and disto buccal, lingual). The article points were removed after 30 seconds with careful attention not to touch the oral mucosa and coronal surfaces. The points were then dropped in plastic sterile falcon tubes.
The RT-PCR analysis was consequently assessed to test the quantitative and qualitative presence of the following pathogens using species-specific probes: A. actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, and Tannerella forsythensis. Results were expressed in Genome Equivalents (Geq)/ mL x 10 3 .
| Radiograph examination
Radiographs were performed immediately at implant placement (T0), at the delivery of definitive crowns 4/6 months after surgery (T1), and 3 years after loading (T3), with a paralleling technique using a Rinn film holder with a rigid film-object x-ray source. For the radiograph To account for radiographic distortion, radiographic measurements on each radiograph were adjusted for a coefficient derived from the ratio: true length of the implant/IL. All measurements were carried out by a single trained examiner who had previously undergone a calibration session for radiographic assessment on a sample of five patients treated with the same implant system and not included in the study (Kappa test = 0.9550, SE of kappa = 0.048, 95% confidence interval: from 0.862 to 1.000).
| Statistical analysis
A public domain online software (Raosoft, http://www.raosoft.com/ samplesize.html) was used to calculate the minimal number necessary for statistical evaluation. Data were analyzed using SPSS software ver- 
| Clinical results
No patients dropped out within the follow-up period. Thus, 20 implants in 20 subjects were evaluated. After 3 years of loading the cumulative survival rate was 100%. A mPI value of 3, 2, 1, and 0, was recorded in 0%, 5%, 16%, and 79% of 80 implant sites, respectively. Eighty-five % of sites presented a bleeding score of 0, while in 10.8%, 4.2%, and 0% of sites the bleeding score was 1, 2, and Regarding KTW, the mean values recorded at crown delivery and after 3 years of loading were 3.94 AE 0.9 mm, and 3.89 AE 1.1 mm, respectively, without significant statistical difference, while the mean value of KTT at the implant placement and after 3 years of function was, 1.96 AE 0.6 mm and 1.89 AE 0.9 mm, respectively. No statistically significant differences were found between sites with KTT >2 mm and ≤2 mm.
| BIOCHEMICAL RESULTS
The mean volumes of PISF in groups A, B, C, and D, were 0.21 AE 1.5, 0.28 AE 0.12, 0.14 AE 0.6, and 0.26 AE 1.1 μL, respectively, without statistically significant difference (P < .05). The mean levels of the IL 1β in groups A, B, C, and D, were 13.53 AE 7. Table 5 shows the amount of five periodontal pathogens present in the saliva samples identified in the groups A, B, C, and D, using RT-PCR. A. actinomycetemcomitans scored <100 in all groups. In group A, the averages of Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, and Tannerella forsythensis were 2.6 x 10 3 (SD 0.9), 3. 14 Analysis of PISF volume and some cytokine levels in the PISF have been suggested in detecting peri-implant inflammatory lesions at an early stage which might be clinically latent. 14 In the present study, in addition to the clinical indices, the volume of PISF, and PISF levels of IL-1β, IL-6, and TNF-α, were assessed. Similarly to gingival crevicular fluid (CGF), PISF is an interstitial fluid that appears in the sulcus because of an osmotic gradient. 17, 30 Several clinical studies, 17, [30] [31] [32] comparing the inflammatory and immunological responses around implants and teeth found no significant difference between PISF and GCF volumes at either healthy or inflamed sites. Inflammatory and immune events were similar in the peri-implant mucosa and gingiva, and GCF and PISF production was governed by similar mechanisms, which depend on peri-implant tissue inflammatory conditions. 30 Furthermore, the volumes of the CGF and PISF appear to be directly related to the severity of the tissue inflammation, as they increase as a function of the greater vascular permeability and ulceration of the epithelium at inflamed sites. Cytokines like interleukin, IL-1β, IL-6, and Few data are present in literature on the influence of the crown margin positions on the peri-implant tissue health, and there is still doubt that the intracrevicular depth of crown margins represents a risk factor in the onset of peri-implant tissue inflammation. [23] [24] [25] Unlike what happens on teeth abutments, on implants, prefabricated prosthetics present less roughness and porosity, and for more commonly used implant systems, imperfections between the various components do not exceed 50 μ. However, it is important to highlight that the host response to a restoration margin depth is of greater clinical importance than merely measuring the presence or levels of any specific bacterial species. *Difference between the group A and groups B, C, and D was statistically significant (P < .05).
| MICROBIOLOGICAL RESULTS
Therefore, the single datum of intracrevicular levels of putative periodontal-pathogens is not sufficient to determine whether the deeper location of restoration margins is a predisposing condition to the onset or development of peri-implant tissue inflammation, and should be at least related to biochemical markers levels found in the same implant sites. In the present study, the difference in subgingival concentration of A. actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, and Tannerella The results of the present study must be interpreted cautiously because of some limitations. In addition to the aforementioned absence of a control group without regular compliance with the supportive periodontal therapy, the small sample size, the short-term follow-up, and the lack of randomization in treatment groups (A, B, C, and D) made causal interpretation difficult. Therefore, final confirmation of findings needs further studies.
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